Adaptive Biotechnologies (ADPT) Capital Leases (2019)
Adaptive Biotechnologies (ADPT) posted Capital Leases of $36.6 million for Q4 2019, up 56.11% sequentially from $23.4 million in Q3 2019.
Adaptive Biotechnologies (ADPT) Capital Leases (2019) Analysis & Trends
Adaptive Biotechnologies has reported Capital Leases for 1 years, with the latest figure at $36.6 million in Q4 2019.
- Quarterly Capital Leases changed N/A year-over-year to $36.6 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $36.6 million (changed N/A YoY) and the FY2019 annual result came in at $36.6 million, changed N/A from the prior year.
- Capital Leases rose to $36.6 million in Q4 2019 per ADPT's latest filing, from $23.4 million in the prior quarter.
- Over five years, Capital Leases peaked at $36.6 million in Q4 2019 and troughed at $23.4 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.77 Bn | 209.71 Bn | 8.34 Bn |
| 2 | Danaher | 139.78 Bn | 135.43 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.04 Bn | 45.85 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.68 Bn | 37.88 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.34 Bn | 37.26 Bn | 1.44 Bn |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn |
| 7 | Illumina | 29.90 Bn | 28.73 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.58 Bn | 28.53 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Adaptive Biotechnologies | 3.83 Bn | 3.61 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 36.61 Mn |
| Sep 30, 2019 | 23.45 Mn |